Learn about SYNT-101, the emerging treatment for obesity that combines the best of two proven methods.

The 74-year-old, who served as an FDA commissioner from 1990 to 1997, turned to GLP-1 medications after battling his weight ...

What are the most concerning consequences of the drug and other weight-loss medicines? - Gastrointestinal and cardiovascular ...

Various diet drugs have been tried over the years, but nearly all have turned out to have dangerous side effects. Wegovy ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...